LCC is an international, chemistry-based CRO on a mission to accelerate your discovery. Its technologies unlock thousands of functionalised (chiral) building blocks that cover some of the gaps in existing 3D chemical space through a combination of novel scaffolds and novel variants of privileged scaffolds. 

LCC’s products are categorised to serve specific hit-identification screening technologies, including: 

(a) monomers and scaffolds for DEL synthesis, 

(b) collections of fragments for FBLD (including covalent, fluoro derivatives and enantioprobes), 

(c) semi-flexible linkers for PROTACs, 

(d) chiral API and intermediates for 'Me-Too' drug discovery. 

With a variety of core technologies and strengths, and facilities that allow production from mg to multi-kg scale, LCC's product pipeline is continuously evolving. Through an ethos of purposeful curiosity, LCC’s goal is to help the development of high-quality drugs, in order to bring new drugs to market faster, better and easier.